1798
E. Georgescu et al.
LETTER
(3) (a) Dürr, H.; Gross, H.; Zils, K.-D.; Hauck, G.; Klauck, G.;
Hermann, H. Chem. Ber. 1983, 116, 3915. (b) Kelderman,
E.; Verboom, W.; Engbersen, J. F. J.; Harkema, S.; Heesink,
G. J. T.; Lehmusvaara, E.; Van Hulst, N. F.; Reinhoudt,
D. N.; Derhaeg, L.; Persoons, A. Chem. Mater. 1992, 4,
626. (c) Nakatsuka, M.; Shimamura, T. JP 2000277263,
2000. (d) Ahmed, S. A. J. Phys. Org. Chem. 2006, 19, 402.
(4) Toyuyama, T.; Unoyama, D.; Brown, G.; Daly, J. W.;
Witkop, B. Helv. Chim. Acta 1974, 57, 2597.
(5) (a) Pearson, W. H.; Fang, W. J. Org. Chem. 2000, 65, 7158.
(b) Wei, L.-L.; Hsung, R. P.; Sklenicka, H. M.; Gerasyuto,
A. I. Angew. Chem. Int. Ed. 2001, 40, 1516. (c) Santarem,
M.; Vanucci-Bacqué, C.; Lhommet, G. J. Org. Chem. 2008,
73, 6466.
tached at the position corresponding to C7 and a carbonyl
group attached to C6).
In conclusion, the three-component reaction of quinolines
with 2-bromoacetophenones and non-symmetrical, elec-
tron-deficient alkynes in 1,2-epoxypropane is an efficient
method for the preparation of a variety of pyrrolo[1,2-
a]quinolines by sequential quaternization, ylide genera-
tion and 1,3-dipolar cycloaddition. Preliminary investiga-
tion indicates that this method could be applied to the
synthesis of other N-fused heterocyclic systems. A sys-
tematic examination of recently determined X-ray struc-
tures of molecules containing the pyrrolo[1,2-a]quinoline
system, including the representative compounds 19 and
44, revealed that the tricyclic system is susceptible to he-
lical distortion induced by bulky substituents. Maximum
distortion was observed when a carbonyl group is attached
to atom C2 of the five-membered ring.
(6) El-Sayed, I. I.; El-Sayed, H. E.-A. Adv. Heterocycl. Chem.
2003, 84, 83.
(7) (a) Henrick, C. A.; Ritchie, E.; Taylor, W. C. Aust. J. Chem.
1967, 20, 2467. (b) Tewari, R. S.; Dubey, A. K.; Misra,
N. K. J. Chem. Eng. Data 1982, 27, 101. (c) Tewari, R. S.;
Dixit, P. D.; Dubey, A. K. J. Chem. Eng. Data 1983, 28,
283. (d) Wei, X.; Hu, Y.; Li, T.; Hu, H. J. Chem. Soc., Perkin
Trans. 1 1993, 2487. (e) Dumitrascu, F.; Mitan, C. I.;
Drăghici, C.; Căproiu, M. T.; Răileanu, D. Tetrahedron Lett.
2001, 42, 8379. (f) Wu, K.; Chen, Q.-Y. Synthesis 2003, 35.
(g) Yue, G.; Wan, Y.; Song, S.; Yang, G.; Chen, Z. Bioorg.
Med. Chem. Lett. 2005, 15, 453.
Acknowledgment
M.R.C. thanks the University of Cape Town and the NRF (Pretoria)
for research support.
(8) (a) Dömling, A. Chem. Rev. 2006, 106, 17.
(b) Multicomponent Reactions; Zhu, J.; Bienayme, H., Eds.;
Wiley-VCH: Weinheim, 2005. (c) Adib, M.; Mohammadi,
B.; Bijanzadeh, H. R. Synlett 2008, 3180. (d) Xie, C.;
Zhang, Y.; Xua, P. Synlett 2008, 3115. (e) Olimpieria, F.;
Volonterio, A.; Zanda, M. Synlett 2008, 3016. (f) Krasavin,
M.; Parchinsky, V. Synlett 2008, 645. (g) Nguyen, R.-V.;
Li, C.-J. Synlett 2008, 1897. (h) Sotoca, E.; Constantieux,
T.; Rodriguez, J. Synlett 2008, 1313. (i) Willy, B.; Müller,
T. J. J. ARKIVOC 2008, (i), 195. (j) Yavari, I.; Souri, S.;
Sirouspour, M. Synlett 2008, 1633. (k) El Kaim, L.;
Gizolme, M.; Grimaud, L. Synlett 2007, 227.
References and Notes
(1) (a) Butin, A. V.; Tsiunchik, F. A.; Abaev, V. T.; Bosikova,
K. V. ARKIVOC 2009, (iv), 79. (b) Liu, X.-Y.; Che, C.-M.
Angew. Chem. Int. Ed. 2008, 47, 3805. (c) Cho, S. H.;
Chang, S. Angew. Chem. Int. Ed. 2008, 47, 2836. (d) Nair,
V.; Devipriya, S.; Suresh, E. Synthesis 2008, 551. (e)Jones,
C. P.; Anderson, K. W.; Buchwald, S. L. J. Org. Chem.
2007, 72, 7968. (f) Kobayashi, K.; Takanohashi, A.; Himei,
Y.; Sano, T.; Fukamachi, S.; Morikawa, O.; Konishi, H.
Heterocycles 2007, 7, 2717. (g) Liu, Y.; Song, Z.; Yan, B.
Org. Lett. 2007, 9, 409. (h) McNab, H.; Reed, D.; Tipping,
I. D.; Tyas, R. G. ARKIVOC 2007, (xi), 85. (i) Seregin, I.
V.; Ryabova, V.; Gevorgyan, V. J. Am. Chem. Soc. 2007,
129, 7742. (j) Hulcoop, D. G.; Lautens, M. Org. Lett. 2007,
9, 1761. (k) Cadogan, J. I. G.; Hewage, C. M.; McNab, H.;
MacPherson, A. D.; Nicolson, I. S.; Reed, D.; Sadler, I. H.
Org. Biomol. Chem. 2006, 4, 2446. (l) Fujita, R.; Hoshino,
M.; Tomishava, H. Chem. Pharm. Bull. 2006, 54, 334.
(m) Kobayashi, K.; Takanohashi, A.; Hashimoto, K.;
Morikawa, O.; Konishi, H. Tetrahedron 2006, 62, 10379.
(n) Tverdokhlebov, A. V.; Gorulya, A. P.; Tolmachev,
A. A.; Kostyuk, A. N.; Chernega, A. N.; Rusanov, E. B.
Synthesis 2005, 2161. (o) Komatsu, M.; Kasano, Y.;
Yamaoka, S.; Minakata, S. Synthesis 2003, 1398.
(l) Stonehouse, J. P.; Chekmarev, D. S.; Ivanova, N. V.;
Lang, S.; Pairaudeau, G.; Smith, N.; Stocks, M. J.; Sviridov,
S. I.; Utkina, L. M. Synlett 2008, 100.
(9) Synthesis of Pyrrolo[1,2-a]quinolines 4–33; General
Procedure: Quinoline 1 (5 mmol), phenacyl bromide 2 (5
mmol) and non-symmetrical acetylene 3 (ethyl propiolate, 3-
butyn-2-one or benzoylacetylene; 7 mmol) in 1,2-epoxy-
propane (40 mL) were stirred at room temperature for 30 h.
The solvent was partly removed by evaporation, then
methanol (10 mL) was added and the mixture was left
overnight at room temperature. The solid was filtered,
washed with a mixture of MeOH–Et2O (1:1) and
recrystallised from CHCl3–MeOH. Ethyl 1-(4-Methyl-
benzoyl)-7-methyl-pyrrolo[1,2-a]quinoline-3-carboxy-
late (19): Yellow crystals with mp 173–175 °C were
obtained by recrystallization from CHCl3–MeOH. Yield:
54%; Anal. Calcd for C24H21NO3: C, 77.61; H, 5.70; N, 3.77.
Found: C, 77.91; H, 5.94; N, 3.98. FT-IR: 1617, 1654, 1704,
2976 cm–1. 1H NMR (300 MHz, CDCl3): d = 1.39 (t, J = 7.1
Hz, 3 H, MeCH2), 2.47 (s, 3 H, MeAr), 2.50 (s, 3 H, 7-Me),
4.39 (q, J = 7.1 Hz, 2 H, CH2), 7.35–7.38 (m, 3 H, H-8, H-3¢,
H-5¢), 7.57 (d, J = 2.1 Hz, 1 H, H-6), 7.62 (s, 1 H, H-2), 7.60
(d, J = 9.3 Hz, 1 H, H-5), 7.87 (d, J = 8.9 Hz, 1 H, H-9), 7.95
(d, J = 8.8 Hz, 2 H, H-2¢, H-6¢), 8.23 (d, J = 9.3 Hz, 1 H, H-
4). 13C NMR (75 MHz, CDCl3): d = 14.5 (MeCH2), 20.8,
21.6 (7-Me, MeAr), 59.9 (OCH2), 107.4 (C-3), 117.6 (C-4),
119.9 (C-9), 125.1, 128.0, 131.4, 135.9, 139.7 (C-1, C-3a, C-
5a, C-9a, C-7), 128.3 (C-6), 129.4 (C-5), 128.6 (C-8), 129.1
(p) Fürstner, A.; Mamane, V. J. Org. Chem. 2002, 67, 6264.
(2) (a) Cappelli, A.; Giuliani, G.; Anzini, M.; Riitano, D.;
Giorgi, G.; Vomero, S. Bioorg. Med. Chem. 2008, 16, 6850.
(b) Anderson, W. K.; De Ruiter, J.; Heider, A. R. J. Org.
Chem. 1985, 50, 722. (c) Ager, I. R.; Barnes, A. C.;
Danswan, G. W.; Hairsine, P. W.; Kay, D. P.; Kennewell,
P. D.; Matharu, S. S.; Miller, P.; Robson, P.; Rowlands,
D. A.; Tully, W. R.; Westwood, R. J. Med. Chem. 1988, 31,
1098. (d) Anderson, W. K.; Heider, A. R.; Raju, N.; Yucht,
J. A. J. Med. Chem. 1988, 31, 2097. (e) Cai, S. X.; Drewe,
J. A.; Jiang, S.; Kasibhatla, S.; Kuemmerle, J. D.; Sirisoma,
N. S.; Zhang, H. Z. WO 2004055163, 2004. (f) Hayford,
A.; Kaloko, J. US Pat 20070293456, 2007. (g) Jones, D. T.;
Harris, A. L. Mol. Cancer Ther. 2007, 5, 2193.
Synlett 2009, No. 11, 1795–1799 © Thieme Stuttgart · New York